WHO has made a written statement regarding the use of the Covovax (NVX-CoV2373) vaccine produced by the Indian Serum Institute under license from the...
Data from Phase 3 trials of the coronavirus vaccine Covaxin, developed in India, has shown that two doses offer 77.8% protection against COVID-19, according...
The World Health Organization (WHO) recommends the widespread use of the first malaria vaccine Mosquirix (RTS, S / AS01), in children in sub-Saharan Africa...